Skip to content
healthcare.dev
Get a free key

Neostigmine Methylsulfate

NDC 0641-6265, Neostigmine Methylsulfate, injection, from Hikma Pharmaceuticals USA Inc..

Product NDC
0641-6265
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207042
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6265 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
0641-6265-100064162651010 VIAL, MULTI-DOSE in 1 CARTON (0641-6265-10) / 10 mL in 1 VIAL, MULTI-DOSE (0641-6265-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/28365ed5-8332-48ac-a93d-b165ac3c6eac

Use it

Look up 0641-6265 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6265 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0641-6265. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.